Loading clinical trials...
Loading clinical trials...
The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
National Jewish Health
Denver, Colorado, United States
Start Date
March 18, 2019
Primary Completion Date
July 1, 2029
Completion Date
July 1, 2032
Last Updated
May 6, 2025
25
ESTIMATED participants
bronchoscopy with intrabronchial administration of lipopolysaccharide
OTHER
Lead Sponsor
National Jewish Health
NCT05847634
NCT05148026
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04725110